Flow Cytometry

PerkinElmer has entered into an agreement to acquire BioLegend, provider of life science antibodies and reagents, for approximately US$5.25 billion. The transaction will be the largest in PerkinElmer’s history and is expected to close by the end of the 2021 calendar year, subject to regulatory approvals and other customary closing conditions. BioLegend provides academic and […]

Marilyn Matz, CEO of Paradigm4, and Zachary Pitluk, Vice President of Life Sciences at Paradigm4, explain why scalable data science platforms are key to supporting integrated analysis of single-cell genomic data sets.  As researchers approach the practical limits of flow cytometry and are challenged to simultaneously explore the thousands of proteins expressed by the genome […]

Bio-Rad has introduced three StarBright Dyes designed for flow cytometry applications. StarBright Violet 570, 670, and 710 Dyes offer improved brightness and precise excitation and emission spectra, making them suitable for use in multicolour flow cytometry panels. The line offers researchers a range of fluorescent nanoparticles conjugated to highly validated flow antibodies. Key benefits of […]

This narrated article is called “Why flow cytometry in drug discovery is a real life-saver”, in which Roy, Global Product Manager at Miltenyi Biotec, outlines the benefits of flow cytometry, offering case study examples for its use. Capable of boasting high-throughput, accurate, multiparameter and highly reproducible results, it’s time for drug discovery industries to look […]

The latest free to listen to DDW podcast episode, titled Flow Cytometry in Drug Discovery, covers an article written by Urmi Roy for DDW, read aloud by Megan Thomas. This article is called “Why flow cytometry in drug discovery is a real life-saver”, in which Roy, Global Product Manager at Miltenyi Biotec, outlines the benefits […]

High-throughput flow cytometry technologies have revolutionised drug screening, says Bio-Rad. This application note explains how you can take throughput and reproducibility to the next level using the ZE5 Cell Analyzer. In the current environment, with increased pressures on drug companies, Bio-Rad believes using effective automation is critical. This application note will cover: How integration of […]

This paid-for app note by Bio-Rad appeared in DDW Volume 22, Issue 1 – Winter 2020/21. As COVID-19 has taken the world by storm, much has been learnt about the various aspects of viral infections ranging from immune surveillance to the therapeutic development of vaccines. One of the technologies that has played a large part in […]

Capable of boasting high-throughput, accurate, multiparameter and highly reproducible results, Urmi Roy, Global Product Manager Miltenyi Biotec outlines the benefits of flow cytometry offering case study examples for its use. Increasing numbers of drug discovery programmes are targeting cellular mechanism and phenotype as a promising avenue for new therapies. The clinical motivation behind this is […]

The human body has the capacity to produce an array of specialised T cells, which provide unique responses to a diverse range of tumour cells and pathogens. In its latest white paper, biopharmaceutical expert, Sartorius, explains why the modulation of T cells is an exciting prospect for the development of novel therapies for immuno-oncology –autoimmune […]

Bio-Rad Laboratories has launched three StarBright Dyes specifically developed for flow cytometry. StarBright Blue 700, StarBright Violet 440, and StarBright Violet 610 are fluorescent nanoparticles that are conjugated to Bio-Rad’s highly validated flow antibodies, providing maximal brightness and improved resolution. Brighter than other fluorescent dyes with similar excitation and emission spectra, the StarBright dyes provide […]